Microscopy analysis revealed that targeting PD-L1+ tumor cells with the chemokine/anti-PD-L1 antibody increased the migration rate of DCs toward the tumor cells (abbreviated TC in the figure) compared to the rate of control cells (Fig. 5e). Here, CD274 is linked to neoplasm.